Glutamine affects glutathione recycling enzymes in a DMBA-induced breast cancer model

Area of Science:

• Biochemistry
• Oncology
• Nutritional Science

Background:

• Malignancy alters host glutathione (GSH) levels, increasing treatment toxicity and tumor resistance.
• Dietary glutamine (GLN) previously showed potential in preventing DMBA-induced mammary tumors by modulating GSH.
• GSH synthesis, metabolism, and recycling involve the gamma-glutamyl cycle.

Purpose of the Study:

• To investigate if GLN prevents DMBA-induced mammary tumors via differential regulation of gamma-glutamyl cycle enzymes.
• To explore the impact of GLN on GSH recycling enzymes in both normal gut tissue and breast tumors.

Main Methods:

• Female Sprague-Dawley rats were assigned to DMBA-tumor bearing, DMBA-treated, or control groups, with subgroups receiving GLN or water.
• Enzyme activities and mRNA levels of key gamma-glutamyl cycle enzymes (GTP, GCS, OPase, GTF, GLNase) were measured in gut mucosa and breast tumors.
• Enzyme assays and semiquantitative reverse transcription polymerase chain reaction (RT-PCR) were employed.

Main Results:

• GLN upregulated gut gamma-glutamyl cycle enzymes (GTP, GCS, OPase, GLNase) in various experimental conditions.
• Conversely, GLN downregulated these same enzymes within the breast tumor tissue.
• A paradoxical effect of GLN on GSH recycling enzymes was observed between the gut and tumor.

Conclusions:

• Dietary GLN exhibits a differential regulatory effect on GSH recycling enzymes in the gut versus tumor.
• Supplemental GLN may enhance the therapeutic index of cancer treatments by protecting normal tissues and sensitizing tumors.
• GLN holds potential clinical application for improving chemotherapy and radiation therapy outcomes.